One such study from 2016 identified seven proteins potentially involved in the pathogenesis of MS, of which secretogranin-1 (Scg1) levels were elevated at the onset of MS as compared to healthy controls and RRMS patients [129]. The gene discussed is CHGB; the disease is myeloid sarcoma.